Volume 27, Number 2—February 2021
Dispatch
Population-Based Serosurvey for Severe Acute Respiratory Syndrome Coronavirus 2 Transmission, Chennai, India
Sriram Selvaraju, Muthusamy Santhosh Kumar, Jeromie Wesley Vivian Thangaraj, Tarun Bhatnagar, Velusamy Saravanakumar, Chethrapilly Purushothaman Girish Kumar, Krithikaa Sekar, Ezhilarasan Ilayaperumal, Ramasamy Sabarinathan, Murugesan Jagadeesan, Masanam Sriramulu Hemalatha, Manoj Vasant Murhekar
, and the Chennai COVID Sero-Surveillance Team
, and the Chennai COVID Sero-Surveillance Team
Table 1
Characteristics of 12,405 participants in a SARS-CoV-2 serosurvey, Chennai, India, July 2020*
| Characteristics | No. (%) |
|---|---|
| Age, y, n = 12,319 | |
| 10–19 | 1,473 (12.0) |
| 20–29 | 2,105 (17.1) |
| 30–39 | 2,353 (19.1) |
| 40–49 | 2,353 (19.1) |
| 50–59 | 1,927 (15.6) |
| >60 |
2,108 (17.1) |
| Sex, n = 12,319 | |
| M | 5,785 (47.0) |
| F | 6,493 (52.7) |
| Transgender |
41 (0.3) |
| History of respiratory symptoms, n = 12,248 | 175 (1.4) |
| Symptomatic persons seeking medical care, n = 175 | 121 (69.1) |
| Hospitalization among persons seeking medical care, n = 121 | 71 (58.7) |
| Reported contact with COVID-19 case, n = 12,248 | 173 (1.4) |
*Among 12,405 persons enrolled in the survey, age and sex data were not available for 86 participants. COVID-19, coronavirus disease; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Page created: December 03, 2020
Page updated: January 24, 2021
Page reviewed: January 24, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.